Clinical Trials Browser

Phase 2 × Non-squamous Non-small Cell Lung Cancer × Bevacizumab × Clear all

NCT05394233 2022-05-27

Tislelizumab +Bevacizumab+pc for Untreated EGFR+ and High PD-L1 Non-squamous NSCLC

Phase 2 Unknown

Non-squamous Non-small Cell Lung Cancer

NCT01057212 2015-09-07

Trial of Bevacizumab and Ixabepilone for Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)

Phase 2 Terminated

Non-squamous Non-small Cell Lung Cancer